What is HD?
HD functions as a comprehensive medtech platform and healthcare solutions provider, bridging the gap between patients and medical services through digital innovation. Based in Bangkok, the company addresses systemic inefficiencies in the healthcare sector by streamlining access to medical procedures and health products. By integrating technology into the patient journey, HD has established itself as a vital intermediary, facilitating better health outcomes while optimizing operational workflows for providers. Their market position is defined by a commitment to digitizing the fragmented healthcare landscape, making them a key target for investors focused on high-growth, technology-enabled businesses in emerging markets.
How much funding has HD raised?
HD has raised a total of $11.6M across 2 funding rounds:
Angel/Seed
$6M
Series A
$5.6M
Angel/Seed (2023): $6M with participation from AC Ventures, Partech International, and iSeed
Series A (2024): $5.6M led by FEBE Ventures, M Venture Partners, and SBI Ven Capital
Key Investors in HD
FEBE Ventures
FEBE Ventures is a global seed-focused venture capital firm founded by ex-founders, providing both financial backing and operational insights to startups in emerging markets.
M Venture Partners
M Venture Partners is a professional fund entity managed by M Capital Management, operating under the regulatory oversight of the Monetary Authority of Singapore.
SBI Ven Capital
SBI Ven Capital is a private equity and credit firm specializing in financial services and technology, with a focus on providing accessible finance solutions across Asia.
What's next for HD?
With the successful closure of this latest financing round, HD is poised to enter a new phase of enterprise-level scaling. The strategic roadmap likely involves deepening its penetration into the Southeast Asian market, enhancing its proprietary technology stack, and expanding its network of healthcare partners. As the firm transitions from its initial growth phase to a more mature operational model, the focus will shift toward sustainable value creation and the potential for further regional dominance. Investors will be monitoring the company's ability to maintain its growth velocity while navigating the complex regulatory and operational environments inherent in the healthcare sector.
See full HD company page
